Market Insights
"The global implantable drug delivery devices market is estimated to grow from USD 10.6 billion in 2020 to USD 16.7 billion by 2026 at a healthy CAGR of 8.0% during the forecast period."

Want to get a free sample? Register Here
Introduction
Implantable drug delivery devices are referred to the medical devices that enable site-specific drug administration. It also enables minimizing doses of the drug to reduce potential side effects. These devices facilitate the sustained release of a therapeutic agent. These implantable devices are gaining popularity over conventional oral or parenteral dosage forms due to the site-specific and sustained-release therapeutic action of implantable devices, which further reduces the side effects associated with the drug.
Market Drivers
The growth of the implantable drug delivery devices market is propelled by a surge in the prevalence of chronic diseases around the world, a rise in demand for minimally invasive drug delivery devices, and unwanted pregnancies over some time. Moreover, strong collaboration activities among leading players are anticipated to offer lucrative growth opportunities for the implantable drug delivery devices market. However, the possibility of implanted device failures as well as stringent government regulations is likely to hamper the industry's growth.
COVID-19 Impact
The COVID-19 outbreak positively influenced the growth of the implantable drug delivery devices market. Also, to protect the population from coronavirus infection, people should keep away from all containment zones including hospitals. This can be possible by implanting drug delivery devices in patients, which offers the advantage of not personally visiting hospitals for follow-ups or treatment procedures as implantable drug delivery devices provide long-term drug delivery. Therefore, the COVID-19 pandemic is likely to augment the implantable drug delivery devices market growth during the review period.
Implantable Drug Delivery Devices Market Report Overview
|
Market Size in 2026
|
USD 16.7 Billion
|
Market Size in 2020
|
USD 10.6 Billion
|
Market Growth (2021-2026)
|
CAGR of 8.0%
|
Base Year of Study
|
2020
|
Trend Period
|
2016-2019
|
Forecast Period
|
2021-2026
|
Key Players
Key players operating in the implantable drug delivery devices market are-
- Allergan PLC (UK)
- Boston Scientific Corporation (US)
- Bausch and Lomb Inc. (Canada)
- Medtronic PLC (UK)
- Alcon Inc. (Switzerland)
- Teleflex Incorporated (US)
- DSM Biomedical (Netherlands)
- Delpor Inc. (US)
- 3M Company (US)
Note: The above list does not necessarily include all the top players in the market.
Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com
Segment Analysis
Application Trends
"The cardiovascular segment accounted for the largest market share."
The market has been classified into contraception, ophthalmology, cardiovascular, diabetes, oncology, autoimmune diseases, and others. The cardiovascular segment accounted for a substantial market share in 2020. This is mainly attributed to an increase in the patient population suffering from cardiovascular diseases, which boosts the clinical urgency to develop advanced devices. As a result, global players have developed bioabsorbable stents which are gradually absorbed and excreted by the body, further bolstering the segment growth.
Regional Insights
"North America accounted for the largest market share."
The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the strong presence of well-developed healthcare infrastructure, increasing investment in R&D activities, the strong prevalence of cardiovascular diseases, higher adoption of these technologies, and favorable government initiatives. Moreover, the favorable reimbursement policies, high rate of R&D activities, and extensive new development activities, further proliferate the regional growth.

Want to get a free sample? Register Here
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.
What deliverables will you get in this report?
Key questions this report answers
|
Relevant contents in the report
|
How big is the sales opportunity?
|
In-depth analysis of the Implantable Drug Delivery Devices Market
|
How lucrative is the future?
|
Market forecast and trend data and emerging trends
|
Which regions offer the best sales opportunities?
|
Global, regional and country level historical data and forecasts
|
Which are the most attractive market segments?
|
Market segment analysis and forecast
|
Which are the top players and their market positioning?
|
Competitive landscape analysis, Market share analysis
|
How complex is the business environment?
|
Porter’s five forces analysis, PEST analysis, Life cycle analysis
|
What are the factors affecting the market?
|
Drivers & challenges
|
Will I get the information on my specific requirement?
|
10% free customization
|
Research Methodology
This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s implantable drug delivery devices market realities and future market possibilities for the forecast period. The report segments and analyzes the market in the most detailed manner to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for the market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate the growth strategies to expedite their growth process.
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.
Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
- Detailed profiling of additional market players (up to three players)
- SWOT analysis of key players (up to three players)
Competitive Benchmarking
- Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.